tiprankstipranks
Advertisement
Advertisement

Hearts and Minds lifts April returns and boosts medical research funding

Story Highlights
  • Hearts and Minds posted a 4.3% April gain, maintains strong long-term returns and a 6.5% fully franked yield.
  • Portfolio gains in tech and semiconductors and a successful SLB call highlight its high-conviction, research-focused strategy.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Hearts and Minds lifts April returns and boosts medical research funding

Meet Samuel – Your Personal Investing Prophet

The latest announcement is out from Hearts and Minds Investments Ltd ( (AU:HM1) ).

Hearts and Minds Investments reported that its portfolio rose 4.3% in April, slightly trailing the MSCI World Accumulation Index (AUD) gain of 5.1%, and has delivered an annualised pre-tax return of 9.4% since its 2018 inception. The company’s pre-tax NTA stood at $3.31 per share versus a $2.92 share price, with a fully franked annualised dividend yield of 6.5% and cumulative medical research funding reaching $90.5 million, underscoring its dual focus on investment performance and philanthropic impact.

Performance in April was driven by strong gains in ACM Research, Amazon and Steel Dynamics, along with continued strength from semiconductor holdings TSMC and NVIDIA, while BlackLine and DiDi Global were notable laggards. Management also highlighted the success of SLB, a global oilfield services and technology company pitched at the 2025 Sohn Hearts & Minds Conference and now up 55% since November, illustrating the ongoing contribution of its manager network and thematic exposure to global energy markets.

More about Hearts and Minds Investments Ltd

Hearts and Minds Investments Ltd is an Australian listed investment company that manages a concentrated, long-only portfolio of 25–35 global securities drawn from high-conviction ideas of respected fund managers. The company forgoes traditional investment fees and instead donates to leading Australian medical research organisations, integrating philanthropic funding with listed equity investing.

Average Trading Volume: 194,126

Technical Sentiment Signal: Sell

For detailed information about HM1 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1